HTL Biotechnology
Valentin T. Fleury is an accomplished professional with extensive experience in strategy, corporate development, and venture capital within the biotechnology and pharmaceutical sectors. Currently serving as the Head of Strategy, Corporate Development & Venture Capital at HTL Biotechnology since October 2020, Valentin also acts as a Board Observer for GelMEDIX, an early-stage biotechnology company focused on ocular and regenerative therapies. Previous roles include membership on the board at JAM. and managerial positions at CEPTON Strategies, where key contributions included the construction of new business models and corporate strategy for pharmaceutical development. Valentin has a solid foundation in consulting and auditing, with relevant expertise in due diligence, market strategies, and financial audits across numerous industries. Valentin holds a Master of Science from Centrale Lyon, a Master in Management from emlyon business school, and a Diplôme de Comptabilité et de Gestion from Conservatoire National des Arts et Métiers.
This person is not in any teams
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.